Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Double Blind (DB) Period: Macitentan	1	64
Total, all-cause mortality	DB Period: Placebo	0	63
Total, all-cause mortality	Open Label (OL) Period: DB Macitentan	0	1
Total, all-cause mortality	OL Period: DB Placebo	0	6
Total, other adverse events	Double Blind (DB) Period: Macitentan	47	64
Total, other adverse events	DB Period: Placebo	38	63
Total, other adverse events	Open Label (OL) Period: DB Macitentan	1	1
Total, other adverse events	OL Period: DB Placebo	5	6
Total, serious adverse events	Double Blind (DB) Period: Macitentan	17	64
Total, serious adverse events	DB Period: Placebo	14	63
Total, serious adverse events	Open Label (OL) Period: DB Macitentan	0	1
Total, serious adverse events	OL Period: DB Placebo	4	6

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04271475/event-totals